Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation

Davis, Mark D.P.; Daoud, Mazen S.; McEvoy, Marian T.; Su, W.P. Daniel

doi:10.1016/s0190-9622(97)80125-9

Cited by 124 publications

(92 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The eosinophil count ranged from 1.3 to 24.0ϫ10 3 /µL. The mean IgE level was 1393 IU/mL (range, 600-3400 IU/mL).…”

Section: Resultsmentioning

confidence: 99%

“…Tlacuilo-Parra et al 7 similarly reported cutaneous manifestations, including palpable purpura, petechiae, nodules, maculopapules, and livedo reticularis, in approximately 51% of patients with CSS. Some reports 3,8 have suggested that clinical papules and nodules on the elbows in patients with CSS are compatible with histologic palisading granulomas in association with vessel-based changes. Sangueza et al 8 described the lesions as palisaded neutrophilic granulomatous dermatitis.…”

Section: Arch Dermatol 2005;141:873-878mentioning

confidence: 99%

See 1 more Smart Citation

Initial Cutaneous Manifestations Consistent With Mononeuropathy Multiplex in Churg-Strauss Syndrome

Kawakami

Soma²,

Kawasaki³

et al. 2005

Arch Dermatol

View full text Add to dashboard Cite

“…The eosinophil count ranged from 1.3 to 24.0ϫ10 3 /µL. The mean IgE level was 1393 IU/mL (range, 600-3400 IU/mL).…”

Section: Resultsmentioning

confidence: 99%

Section: Arch Dermatol 2005;141:873-878mentioning

confidence: 99%

Initial Cutaneous Manifestations Consistent With Mononeuropathy Multiplex in Churg-Strauss Syndrome

Kawakami

Soma²,

Kawasaki³

et al. 2005

Arch Dermatol

View full text Add to dashboard Cite

“…Podem surgir miocardites, pericardites e doença coronariana, sendo as lesões cardíacas a causa de óbito em 40% dos doentes. [32][33][34] As manifestações cutâneas ocorrem em cerca de 50% dos casos: púrpura palpável em 48% dos casos, nódulos subcutâneos em 30%, erupção maculopapulosa em 25%, erupções urticariformes em 25% dos pacientes. 29 O prognóstico da SCS é melhor do que o da PAN ou da GW.…”

Section: Síndrome De Churg-straussunclassified

Vasculites dos médios e grandes vasos

Brandt

Arnone

Valente

et al. 2009

An. Bras. Dermatol.

View full text Add to dashboard Cite

Resumo:As vasculites são constituídas por um grande grupo de síndromes caracterizadas por inflamação e necrose da parede dos vasos sangüíneos, resultando em estreitamento ou oclusão do lúmen. A distribuição dos vasos envolvidos varia consideravelmente e serve de base para a classificação das síndromes vasculíticas: grandes vasos (arterite de Takayasu, arterite temporal); pequenos e médios vasos (poliarterite nodosa, síndrome de Churg-Strauss, granulomatose de Wegener, vasculites nas doenças reumáticas); e pequenos vasos (vasculite de hipersensibilidade, púrpura de Henoch-Schonlein, poliangeíte microscópica, crioglobulinemia). Este artigo revisa as vasculites dos médios e grandes vasos e opções terapêuticas atuais; além de oferecer orientação sobre abordagem diagnóstica e tratamento dos pacientes com suspeita de vasculite cutânea. Palavras-chave: Anticorpos anticitoplasma de neutrófilos; Arterite de células gigantes; Arterite de Takayasu; Doenças reumáticas; Granulomatose de Wegener; Poliarterite nodosa; Púrpura; Síndrome de Churg-Strauss; Vasculite; Vasculite alérgica cutânea Abstract: Vasculitis comprises a broad group of syndromes characterized by inflammation and necrosis on the walls of blood vessels, resulting in narrowing or occlusion of the lumen. The distribution of involved blood vessel varies considerably and serves as the basis for one classification of vasculitic syndromes: large vessels (Takayasu arteritis, giant cell arteritis); medium and small muscular arteries (polyarteritis nodosa, Churg-Strauss syndrome, Wegener's granulomatosis, vasculitis in rheumatic diseases); and small vessels ("hypersensitivity" vasculitis, Henoch-Schonlein purpura, microscopic polyangiitis, cryoglobulinemia). This article reviews medium and large vessel vasculitis and current treatment options; it also presents a comprehensive approach to diagnosing and treating patients with suspected cutaneous vasculitis.

show abstract

“…[16][17][18] Common dermatologic manifestations of Churg-Strauss syndrome are palpable purpura, hemorrhagic lesions (ranging from petechiae to extensive ecchymosis), cutaneous and subcutaneous nodules, erythematous maculopapules, and, rarely, ulcers, infarcts, livedo-like eruption and facial edema. 19 It is thought that the decreased corticosteroid dosage needed to control asthma symptoms in patients receiving leukotriene receptor antagonists unmasks an underlying vasculitis that had been controlled previously by the corticosteroids. 17,18,20,21 Our patient was not receiving oral corticosteroid.…”

Section: Discussionmentioning

confidence: 99%

A Rare Adverse Effect of Montelukast Treatment: Ecchymosis

et al. 2013

View full text Add to dashboard Cite

Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.

show abstract

Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation

Cited by 124 publications

References 17 publications

Initial Cutaneous Manifestations Consistent With Mononeuropathy Multiplex in Churg-Strauss Syndrome

Initial Cutaneous Manifestations Consistent With Mononeuropathy Multiplex in Churg-Strauss Syndrome

Vasculites dos médios e grandes vasos

A Rare Adverse Effect of Montelukast Treatment: Ecchymosis

Contact Info

Product

Resources

About